References
Touya JJ, Rahimian J, Grubbs DE, Corbus HF, Bennet LR. A noninvasive procedure forin vivo assay of a lung amine endothelial receptor.J Nucl Med 26: 1302–1307, 1985.
Suga K, Ariyoshi I, Nakanishi T, Utsumi H, Yamada N. Altered kinetics of123I-IMP in irradiated rabbit lungs.Nucl Med Commun 13: 282–289, 1992.
Suga K, Ariyoshi I, Nakanishi I, Utsumi H, Yamada N. Clinical and experimental studies on the mechanism of abnormal accumulation in lung scanning with123I-IMP.Nucl Med Commun 13: 33–40, 1992.
Suga K, Matsumoto T, Nakanishi T, Yokoyama T, Tanaka K, Nakamura H, et al. Clinical study on the mechanism of abnormal accumulation in lung scanning with N-isopropyl- p-I-123-iodoamphetamine (123I-IMP).Jpn J Nucl Med 25: 625–631, 1988.
Suematsu T, Narabayashi I, Takada Y, Ohbayashi K, Hirata Y, Oshitani T, et al. Delayed lung scintigraphy with N- isopropyl-I-123-p-iodoamphetamine in lung cancer and inflammatory disease.Jpn J Nucl Med 26: 45–53, 1989.
Nakajyo M, Nakabeppu Y, Iwashita S, Tanoue T, Taguchi M, Shinohara S. Differentiation of infiltrates between lung cancer and noncancerous lung disease by123I-IMP lung imaging.Nippon Acta Radiol 50: 164–171, 1990.
Nakajyo M, Uchiyama N, Shimada J, Shinohara S, Iriki A, Hirotsu Y, et al. Differentiation of bronchogenic carcinoma from secondary changes, obstructive pneumonia and/or collapse by123I-IMP lung imaging.Ann Nucl Med 4: 1–13, 1990.
Nakajyo N, Shimada J, Shimozono M, Uchiyama N, Hiraki Y, Shinohara S. Serial lung imaging with123I-IMP in local- ized pulmonary lesions.Jpn J Nucl Med 25: 441–450, 1988.
Kosuda S, Kawahara S, Tamura K, Ishikawa N, Ono A, Kubo A, et al. N-isopropyl-p-[I-123]Iodoamphetamine lung imaging in a patient with chronic pulmonary thrombo- embolism.Clin Nucl Med 14: 756–758, 1989.
Mena I, Thompson C, Mason G. Lung first-pass extraction of N-isopropyl-p-I-123-iodoamphetamine in patients with chronic obstructive pulmonary disease.Clin Nucl Med 9: 5–38, 1984.
Ikeda H, Mariko M, Komatsu M, Takahashi K, Yasui S, Takahashi K. Prolonged123I-IMP retention in pulmonary disease.Eur J Nucl Med 15: 646–648, 1989.
Kato K, Harada S, Takahashi T, Katsuragawa S, Yanagisawa T. Effects of cigarette smoking on iodine 123 N-isopropyl- p-iodoamphetamine clearance from the lung.Eur J Nucl Med 18: 801–805, 1991.
Balikian JP, Herman PG. Non-Hodgkin’s lymphoma of the lungs.Radiology 132: 569–576, 1979.
Bosanko CMM, Korobkin M, Fantone JC, Rubin SB, Lynch JP. Lobar primary pulmonary lymphoma: CT findings.J Comput Assist Tomogr 15: 679–682, 1991.
Rahimian J, Glass EC, Touya JJ, Akber SF, Graham LS, Bennet LR. Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique.J Nucl Med 25: 31–37, 1984.
L’Hoste RJ, Filippa DA, Lieberman PH, Bretsky S. Primary pulmonary lymphomas. A clinicopathologic analysis of 36 cases.Cancer 54: 1387–1406, 1984.
Freeman CB, Berg JW, Cuttler SJ. Occurence and progno- sis of extranodal lymphoma.Cancer 29: 252–260, 1972.
Hansmann GML, Zwingers T, Lennert K. Primary lym- phomas of the lung: morphological, immunohistochemical and clinical features.Histopathology 16: 519–531, 1990.
Turner RR, Colby TV, Dogget RS. Well-differentiated lymphocytic lymphoma—A study of 47 patients with pri- mary manifestation in the lung.Cancer 54: 2088–2094, 1984.
Lewis ER, Caskey CI, Fishman EK. Lymphoma of the lung: CT findings in 31 patients.AJR 156: 711–714, 1991.
Koss M, Hochholzer L, Nichols PW, Wehunt W, Lazarus A. A primary non-Hodgkin’s lymphoma and pseudo- lymphoma of the lung. A study of 161 patients.Hum Pathol 14: 1024–1038, 1983.
Weiss LM, Yousem SA, Warnke RA. Non-Hodgkin’s lymphomas of the lung—A study of 19 cases emphasizing the utility of frozen section immunologic studies in differ- ential diagnosis.Am J Surg Patholo 9: 490–496, 1985.
Kennedy JL, Hathwani N, Burke J, Hill LR, Rappaport H. Pulmonary lymphomas and other pulmonary lymphoid lesions—A clinicopathological and immunologic study of 64 patients.Cancer 56: 539–552, 1985.
Rights and permissions
About this article
Cite this article
Suga, K. I-123 IMP scintigraphy in two patients with primary pulmonary malignant lymphoma. Ann Nucl Med 8, 65–69 (1994). https://doi.org/10.1007/BF03164988
Issue Date:
DOI: https://doi.org/10.1007/BF03164988